UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A7L1V143 | GFRA1 protein (Fragment) |
|
2 | 0 |
|
A0A7L1V1D2 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7L1VGH7 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L1UY31 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7L1V154 | NOGG protein (Fragment) |
|
1 | 0 |
|
A0A7L1VKT4 | Fibroblast growth factor receptor 1 (Fragment) |
|
8 | 0 |
|
A0A7L1UVC6 | Protein adenylyltransferase FICD (Fragment) |
|
1 | 0 |
|
A0A7L1V280 | Phosphoinositide phospholipase C (Fragment) |
|
2 | 0 |
|
A0A7L1V265 | AMD monooxygenase (Fragment) |
|
1 | 0 |
|
A0A7L1VAT0 | Voltage-dependent L-type calcium channel subunit alpha-1C (Fragment) |
|
1 | 0 |
|
A0A7L1V2H1 | Rhodopsin (Fragment) |
|
1 | 0 |
|
A0A7L1UYM3 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L1VE62 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7L1V5W1 | Fibroblast growth factor receptor 2 (Fragment) |
|
8 | 0 |
|
A0A7L1VKE9 | P2X purinoceptor (Fragment) |
|
1 | 0 |
|
A0A7L1VQL9 | Angiotensin-converting enzyme (Fragment) |
|
2 | 0 |
|
A0A7L1VKF3 | KCNKG protein (Fragment) |
|
1 | 0 |
|
A0A7L1UYJ7 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7L1VNJ9 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L1VCZ4 | BACE2 secretase (Fragment) |
|
1 | 0 |
|
A0A7L1VPX2 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7L1VNR1 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L1UYA9 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7L1UQ58 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L1UUP5 | RET kinase (Fragment) |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024